Skip to main content

Table 1 Comparison of clinical data between two groups of patients with recurrent colorectal liver metastases after hepatectomy

From: Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy

Variable

 

RFA (n = 144)

Repeat hepatic resection (n = 50)

χ2

P

v

Sex ratio (n)

Male:Female

87:57:00

33:17:00

0.674

0.411

1

Age(years)

≤ 60

66 (45.8)

21 (42.0)

0.293

0.588

1

> 60

78 (54.2)

29 (58.0)

Primary tumors location (n%)

Colon

90 (62.5)

30 (60.0)

0.132

0.717

1

Rectum

54 (37.5)

20 (40.0)

Timing of liver metastases (n%)

Synchronous

117 (81.3)

35 (70.0)

3.466

0.063

1

Metachronous

27 (18.7)

15 (30.0)

Distribution of liver metastases (n%)

Unilobar

75 (52.1)

36 (72.0)

8.409

0.004

1

Bilobar

69 (47.9)

14 (28.0)

Preoperative chemotherapy (n%)

 

64 (44.4)

15 (30.0)

4.438

0.035

1

CEA (ng/ml)

≤ 10

87 (60.4)

34 (68.0)

1.257

0.262

1

> 10

57 (39.6)

16 (32.0)

Size of tumors (cm)

≤ 3

102 (70.8)

37 (74.0)

0.256

0.613

1

> 3

42 (29.2)

13 (26.0)

Number of metastatic tumors (n%)

Solitary

63 (43.8)

30 (60.0)

5.256

0.022

1

Multiple

81 (56.2)

20 (40.0)

Relapse time interval (months)

≤ 6

57 (39.6)

14 (28.0)

3.007

0.083

1

> 6

87 (60.4)

36 (72.0)

  1. Values in parentheses are percentages; RFA radiofrequency ablation, CEA carcinoembryonic antigen